hVIVO Plc. HVO
Dividend Summary
The previous hVIVO Plc. dividend was 0.45p and it went ex 7 months ago and it was paid 6 months ago.
There have not been any declared dividends recently.
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | Paid | – |
| Type | Special | – |
| Per share | 0.45p | – |
| Declaration date | 25 Apr 2023 (Tue) | – |
| Ex-div date | 04 May 2023 (Thu) | – |
| Pay date | 09 Jun 2023 (Fri) | – |
Enter the number of hVIVO Plc. shares you hold and we'll calculate your dividend payments:
Sign up for hVIVO Plc. and we'll email you the dividend information when they declare.
Add hVIVO Plc. to receive free notifications when they declare their dividends.
Your account is set up to receive hVIVO Plc. notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| Paid | Special | 25 Apr 2023 | 04 May 2023 | 09 Jun 2023 | GBP | — | 0.45p |
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0p | — |
| 2007 | 0.0p | 0% |
| 2008 | 0.0p | 0% |
| 2009 | 0.0p | 0% |
| 2010 | 0.0p | 0% |
| 2011 | 0.0p | 0% |
| 2012 | 0.0p | 0% |
| 2013 | 0.0p | 0% |
| 2014 | 0.0p | 0% |
| 2015 | 0.0p | 0% |
| 2016 | 0.0p | 0% |
| 2017 | 0.0p | 0% |
| 2018 | 0.0p | 0% |
| 2019 | 0.0p | 0% |
| 2020 | 0.0p | 0% |
| 2021 | 0.0p | 0% |
| 2022 | 0.0p | 0% |
| 2023 | Sign Up Required | |
hVIVO Plc. Optimized Dividend Chart
- Dividend Yield Today
- 0.0%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 0.0% on 30 November 2022
- 52 Week Low
- 0.0% on 30 November 2022
- Next Ex-Div-Date Countdown
- Sign Up Required
About hVIVO Plc.
Open Orphan plc, formerly Venn Life Sciences Holdings plc, is engaged in the pharma services business. The Company is also engaged in building an orphan drug consulting services platform that helps pharma companies commercialize their products in Europe. The Company consists of four elements: a European clinical research organization and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians, and a Health Data Platform. The Company provides fragmented orphan drug services. The Company acquires and consolidates series of orphan drug services companies. It also provides digital data platforms to support companies in research & development and commercialization.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- United Kingdom
- Share Price
- £0.21 (yesterday's closing price)
- Shares in Issue
- 680 million
- Market Cap
- £139mn
- 0
- Market Indices
- none
